Essais liés5clinical trials
VilleLimogeslocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT01285765

Ouvrir le site du centre

Essais cliniques associés

5
MoléculeIndication / populationPhaseNCTTitreStatut
RCHOP21 SEP Phase 3 NCT01285765 Evaluate a Treatment Adapted to the PET Response Compared to a Standard Treatment, for Low Risk DLBCL CD 20+ Patients COMPLETED
BIOPARK — Biomarkers in Parkinsonian Syndromes Parkinson À vérifier NCT02114242 BIOPARK — Biomarkers in Parkinsonian Syndromes UNKNOWN
Ocrelizumab Injection [Ocrevus] SEP Phase 3 NCT05999604 WINDOCRE — Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial ACTIVE_NOT_RECRUITING
MRI Evaluation SEP Non applicable NCT03455582 PRO-COG — Cognition Evolution and MRI Markers in PPMS Patients on 2 Years COMPLETED
Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi) Lupus NA NCT02732470 Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi) COMPLETED